Global Vaccine Contract Manufacturing Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

Increasing Outsourcing of Vaccine Manufacturing and Emergence of Single-Use Technologies Drive Growth in the Vaccine Contract Manufacturing Market

• The COVID-19 pandemic has had a significant impact on the vaccine contract manufacturing market. The lockdown measures during the pandemic resulted in a shortage of vaccines for various diseases, which impeded the growth of the vaccine contract manufacturing market. However, there was a rapid acceleration in research and development, as well as clinical trials worldwide to develop safe and effective vaccines for COVID-19, leading to increased demand and manufacturing of vaccines and ultimately driving the growth of the market.
• Technological advancements and cost benefits, such as continuous manufacturing and automation, are driving factors in the vaccine contract manufacturing market. Continuous manufacturing, which involves uninterrupted production processes, allows for faster and more efficient production. Automation in vaccine manufacturing can reduce the risk of human error, increase efficiency, and lower costs. Robotics can perform repetitive tasks, such as filling and labeling, resulting in higher throughput and reduced labor costs.
• Despite these drivers, the high costs associated with vaccine manufacturing pose a challenge to the market. The cost of vaccines is influenced by various factors, including research and development costs, manufacturing costs, distribution costs, and regulatory requirements. Manufacturing vaccines requires specialized equipment and facilities, and maintaining high-quality control standards adds to the costs. However, favorable government policies and guidelines aimed at ensuring widespread vaccination coverage present an opportunity for the vaccine contract manufacturing market to grow in the forecast period.
• Another challenge for the market is the trend of pharmaceutical companies opting to manufacture their products in-house to gain strategic control over the manufacturing process. This can be a complex and time-consuming process that requires significant investments in infrastructure, equipment, and personnel. However, some pharmaceutical companies may choose this approach, posing a challenge to the vaccine contract manufacturing market.

Market Segmentations

• The Global Vaccine Contract Manufacturing Market is segmented based on Function, Type, Applications, and Geography.
• By Vaccine Type, the market is segmented into various types of vaccines, including Attenuated vaccine, DNA Vaccines, Inactivated Vaccine, Live-attenuated Vaccines, RNA Vaccines, Subunit Vaccines, and Toxoid Vaccines. Among these, inactivated vaccines and live-attenuated vaccines are currently the most widely used types of vaccines. Inactivated vaccines, such as the flu vaccine and the polio vaccine, are popular due to their safety and effectiveness, and they can be manufactured using traditional methods.
• By Function, the market is categorized into two segments: Downstream and Upstream. Both downstream and upstream processing is crucial in vaccine manufacturing, and the market share for each segment can vary based on the client's specific requirements and the type of vaccine being developed. However, in general, upstream processing, which involves more complex and costly steps, may account for a larger portion of the market share compared to downstream processing.
• By Applications, the market is divided into two categories: Human Use and Veterinary. Human vaccines typically hold a larger market share compared to veterinary vaccines, owing to the larger global population of humans compared to animals and the higher demand for vaccines to prevent and manage infectious diseases in humans.
• By Geography, the market is categorized into regions including the Americas, Europe, Middle East & Africa, and Asia-Pacific. The Asia-Pacific region is known to have the largest market share due to its large population and significant healthcare development. Additionally, various government initiatives aimed at increasing vaccination awareness are driving the growth of the market in the region during the forecast period.

Recent Development

• Moderna has agreed with the Canadian government to establish a manufacturing facility for messenger RNA (mRNA) vaccines in an undisclosed location in Canada. This partnership aims to provide Canadians with access to mRNA vaccines produced within Canada to combat respiratory viruses such as SARS-CoV-2, influenza, and respiratory syncytial virus, as stated by the biotech company. - August 2022

Merck and Agilent Technologies have joined forces in a collaborative effort to advance process analytical technologies for downstream processing and address the existing gaps in this area. - June 2022

Company Profiles

Countries Studied

• America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
• Europe (Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Luxemburg, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
• Middle East and Africa (Egypt, Israel, Qatar, Nigeria, Saudi Arabia, South Africa, United Arab Emirates, and the Rest of MEA)
• Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

Ansoff Analysis

• The report presents a detailed Ansoff matrix analysis for the Global Vaccine Contract Manufacturing Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development, and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
• The publisher analyses the Global Vaccine Contract Manufacturing Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
• Based on the SWOT analysis conducted on the industry and industry players, the publisher has devised suitable strategies for market growth.

Why buy this report?

• The report offers a comprehensive evaluation of the Global Vaccine Contract Manufacturing Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
• The research report also provides a detailed market size analysis and projections in volume and value terms. The projections are calculated using verified research methodologies.
• Excel data sheet for the market size will also be provided with the report.
• The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
• The report includes an in-depth market analysis using Porter’s 5 forces model, PESTLE Analysis, and the Ansoff Matrix. In addition, the impact of COVID-19 on the market is also featured in the report.
• The report includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
• The report includes Self-Assessment Form, which helps customers evaluate their position in the market compared to their competitors.
• The report offers customized research - tailored uniquely to our customers with a quick turnaround time. We offer a 15% customization option at no extra charge to all our clients for any of our syndicated reports.

Report Highlights:

• A complete analysis of the market, including the parent industry
• Important market dynamics and trends
• Impact Analysis - a comprehensive assessment to confront risk and make strategic & operational decisions to counter the changes in the market environment
• Market segmentation
• Competitive Analysis: Comparative analysis of competitor
• Historical, current, and projected size of the market based on value and volume
• Market size of the US states
• Market shares and strategies of key players
• Recommendations to companies for strengthening their foothold in the market